Latest Ratios: P/E Ratio 9.9x · EV/EBITDA N/A · ROE 22.1%. (2015–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $174M | $464M | $684M | $805M | $941M | $624M | $595M | $453M | $305M | $359M | — |
| Enterprise Value | $222M | $511M | $735M | $781M | $976M | $575M | $608M | $461M | $349M | $411M | — |
| P/E Ratio → | 9.88 | 14.22 | 11.64 | 13.55 | 16.47 | 13.30 | 17.64 | 23.15 | — | — | — |
| P/S Ratio | 0.41 | 0.76 | 1.04 | 1.22 | 1.72 | 1.36 | 1.67 | 1.42 | 1.11 | 1.79 | — |
| P/B Ratio | 1.08 | 2.88 | 5.07 | 5.40 | 6.28 | 4.36 | 6.32 | 8.09 | 6.85 | 10.00 | — |
| P/FCF | 3.66 | 29.32 | 29.64 | 6.16 | 313.66 | 9.24 | — | 9.83 | 21.01 | 117.10 | — |
| P/OCF | 4.72 | 12.57 | 12.89 | 5.61 | 62.03 | 7.99 | — | 8.62 | 15.36 | 48.39 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.84 | 1.12 | 1.19 | 1.78 | 1.25 | 1.70 | 1.44 | 1.27 | 2.05 | — |
| EV / EBITDA | — | 6.00 | 6.77 | 7.21 | 10.56 | 7.43 | 9.55 | 9.39 | 12.14 | 22.28 | — |
| EV / EBIT | 3.26 | 8.68 | 7.74 | 8.18 | 11.77 | 8.47 | 11.50 | 12.66 | 26.70 | — | — |
| EV / FCF | — | 32.34 | 31.85 | 5.98 | 325.07 | 8.51 | — | 10.01 | 24.06 | 134.15 | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.0% | 36.0% | 89.6% | 33.8% | 33.3% | 33.0% | 33.2% | 33.5% | 33.4% | 32.6% | 34.7% |
| Operating Margin | 11.2% | 11.2% | 14.4% | 14.5% | 15.2% | 14.8% | 14.8% | 11.4% | 4.8% | 0.9% | 13.9% |
| Net Profit Margin | 5.4% | 5.4% | 8.9% | 9.0% | 10.5% | 10.2% | 9.5% | 6.1% | -2.6% | -5.1% | 5.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 22.1% | 22.1% | 41.4% | 39.8% | 39.1% | 39.5% | 45.0% | 39.0% | -18.0% | -52.0% | 572.9% |
| ROA | 6.7% | 6.7% | 11.3% | 10.9% | 13.4% | 15.6% | 13.9% | 8.7% | -3.3% | -6.1% | 15.8% |
| ROIC | 25.8% | 25.8% | 45.7% | 46.2% | 44.8% | 50.7% | 46.2% | 35.7% | 11.1% | 2.1% | 79.0% |
| ROCE | 19.8% | 19.8% | 28.6% | 28.1% | 30.1% | 34.0% | 33.1% | 24.2% | 8.7% | 1.6% | 57.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.34 | 1.34 | 1.35 | 1.45 | 1.23 | 0.58 | 0.93 | 1.69 | 2.64 | 3.10 | 23.95 |
| Debt / EBITDA | 2.54 | 2.54 | 1.67 | 1.99 | 1.99 | 1.07 | 1.38 | 1.93 | 4.08 | 6.04 | 3.05 |
| Net Debt / Equity | — | 0.30 | 0.38 | -0.16 | 0.23 | -0.35 | 0.13 | 0.15 | 0.99 | 1.46 | 12.41 |
| Net Debt / EBITDA | 0.56 | 0.56 | 0.47 | -0.22 | 0.37 | -0.64 | 0.20 | 0.17 | 1.54 | 2.83 | 1.58 |
| Debt / FCF | — | 3.02 | 2.22 | -0.18 | 11.41 | -0.73 | — | 0.19 | 3.05 | 17.06 | 2.09 |
| Interest Coverage | 4.98 | 4.98 | 8.09 | 9.16 | 14.73 | 14.96 | 8.05 | 4.28 | 0.71 | -0.27 | 2.41 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.51 | 2.51 | 1.96 | 1.94 | 2.07 | 2.26 | 2.22 | 1.77 | 2.04 | 1.64 | 2.01 |
| Quick Ratio | 2.51 | 2.51 | 1.96 | 1.94 | 2.07 | 2.26 | 2.22 | 1.77 | 2.04 | 1.64 | 2.01 |
| Cash Ratio | 1.20 | 1.20 | 0.86 | 1.07 | 0.81 | 1.13 | 0.89 | 1.03 | 1.07 | 0.81 | 0.98 |
| Asset Turnover | — | 1.17 | 1.42 | 1.14 | 1.07 | 1.35 | 1.38 | 1.41 | 1.21 | 0.93 | 1.39 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 64.36 | 60.49 | 86.85 | 87.52 | 54.09 | 56.69 | 45.40 | 47.70 | 93.27 | 61.28 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | 5.6% | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | 13.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 10.1% | 7.0% | 8.6% | 7.4% | 6.1% | 7.5% | 5.7% | 4.3% | — | — | — |
| FCF Yield | 27.4% | 3.4% | 3.4% | 16.2% | 0.3% | 10.8% | — | 10.2% | 4.8% | 0.9% | — |
| Buyback Yield | 9.4% | 3.5% | 11.0% | 8.2% | 5.7% | 0.9% | 0.0% | 0.0% | 0.0% | 31.8% | — |
| Total Shareholder Yield | 9.4% | 3.5% | 11.0% | 8.2% | 5.7% | 0.9% | 0.0% | 0.0% | 0.0% | 37.4% | — |
| Shares Outstanding | — | $30M | $33M | $36M | $39M | $39M | $38M | $38M | $25M | $36M | $36M |
Includes 30+ ratios · 11 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying IMXI stock.
International Money Express, Inc.'s current P/E ratio is 9.9x. The historical average is 15.7x.
International Money Express, Inc.'s return on equity (ROE) is 22.1%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 21.8%.
Based on historical data, International Money Express, Inc. is trading at a P/E of 9.9x. Compare with industry peers and growth rates for a complete picture.
International Money Express, Inc. has 36.0% gross margin and 11.2% operating margin. Operating margin between 10-20% is typical for established companies.
International Money Express, Inc.'s Debt/EBITDA ratio is 2.5x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
Revenue erosion outpacing cost flexibility
Metrics are mathematically derived from official filings.
Cheap Multiples Reflect Earnings Unreliability
At 11.4x trailing earnings and 4.9x EV/EBITDA, IMXI trades at a steep discount to Euronet Worldwide's 9.1x P/E and 4.3x EV/EBITDA, yet its PEG of 2.68 suggests the market prices limited growth, and the discount appears to reflect earnings-quality concerns rather than pure value.
The headline multiples look inexpensive against the payment-infrastructure peer set, but the 1.4-point P/E premium to Euronet and the 23.5x P/FCF imply investors are unwilling to capitalize volatile earnings. The forward P/E rising to 14.7x versus trailing 11.4x signals an expectation of weaker per-share earnings ahead, consistent with the two-year revenue contraction. Relative to Western Union at 4.0x P/E and a 15.4% dividend yield, IMXI offers neither the cyclical-value nor income profile that would justify chasing the multiple on a multiple-only thesis, so the discount appears structural until revenue stabilizes.
Margins Too Volatile for Earnings Power Read
IMXI's operating margin swung from 16.2% in 2024Q3 to -106.3% in 2025Q4 before recovering to 6.7% in 2026Q2, a range that suggests reported profitability is not yet a dependable measure of the company's underlying earning capacity as revenue has roughly halved.
The gross margin line is the least usable metric here, having printed 90.0% in 2024Q3 and -179.0% in 2025Q4, which points to settlement-related cost accounting rather than true production economics, so normalized operating margin in the mid-single-digit zone is the more defensible reference point. Net income remaining positive in 2025Q4 ($8.9M) and 2026Q1 despite operating losses of -$64.1M and -$11.5M suggests tax or non-operating items are cushioning reported results, meaning the more conservative read-through is that core earning power is currently sub-10% of revenue. With R&D reported at zero and SG&A fluctuating between $10.0M and $33.8M without revenue correlation, investors should monitor whether the 6.7% operating margin in 2026Q2 holds as revenue normalizes lower.
Returns Decay Below Cost of Capital
IMXI's ROIC has deteriorated from 14.1% in 2024Q3 to 3.2% in 2026Q2, with a deeply negative -24.8% print in 2025Q4, indicating the company has moved from compounding returns on invested capital to generating a fraction of what the asset base requires.
The decline appears driven more by shrinking revenue against a still-meaningful asset base than by margin compression alone, as asset turnover has slipped from 0.35x in 2024Q4 to 0.26x in 2026Q2 while total assets contracted 27% from their 2024Q2 peak. ROE tells a similar story but decouples oddly from ROIC in 2025Q4 (5.7% ROE versus -24.8% ROIC), which likely reflects the small equity base and non-operating gains rather than operating return recovery, so ROE overstates true performance in that quarter. A 3.2% ROIC is well below any reasonable cost-of-capital estimate for a technology-infrastructure business, implying that reported net income in recent quarters may not represent genuine economic value creation, and sustained sub-5% ROIC would warrant further investigation of asset quality on the balance sheet.
Settlement Float Masks Operating Efficiency
IMXI's DSO has lengthened from 66 days in 2024Q4 to 174 days in 2025Q4 before easing to 72 days in 2026Q2, a volatility pattern that reflects settlement-float timing rather than genuine working-capital management, obscuring any real efficiency trend.
The cash conversion cycle cannot be reliably computed because inventory days are consistently unavailable for a non-manufacturing settlement business, so DSO and DPO must be interpreted in isolation: DPO has oscillated between 9 and 32 days with an outlier of 182 days in 2024Q3, again suggesting payment-cycle timing rather than supplier leverage. Asset turnover at 0.12x-0.35x across the period remains structurally low versus what pure software-infrastructure peers typically achieve, indicating the balance sheet carries settlement assets that do not scale with the top line. Since working-capital swings have accounted for nearly all divergence between reported net income and operating cash flow, these efficiency ratios should be treated as noise rather than as evidence of improving or deteriorating operating discipline.
Deleveraging Accompanies a Shrinking Base
As reported in IMXI's balance sheet, the debt-to-equity ratio has fallen from 1.67 in 2024Q2 to 0.80 in 2026Q2 alongside roughly $102M of debt reduction, while interest coverage has weakened from 10.15x in 2024Q4 to 3.77x as earnings power declined.
The leverage direction is favorable in isolation, but the deteriorating interest coverage ratio from double-digits to 3.77x indicates the improvement is partly a function of shrinking earnings rather than purely aggressive repayment, so the ratio may not reflect the comfort level it suggests. Current ratio at 1.96 and quick ratio identical to it suggest a liquid, inventory-light balance sheet that would likely withstand moderate stress, though the 35% decline in cash from the $233.2M peak to $150.6M in 2026Q2 narrows the buffer that earlier deleveraging created. With debt-to-EBITDA at 10.0x in 2026Q2 versus 6.97x in 2025Q2, the leverage metrics read as manageable only if EBITDA recovers toward 2025 levels; continued margin compression would put refinancing and covenant discussions back into focus.
P/E Misapplied to Settlement Businesses
The most commonly misapplied ratio for IMXI is the price-to-earnings multiple, which currently reads an attractive 11.4x but capitalizes net income that has been repeatedly flattered by non-operating items and volatile settlement-related cost accounting, obscuring the underlying operating trajectory.
Because reported net income in 2025Q4 and 2026Q1 stayed positive despite large operating losses, the P/E ratio compares the share price against earnings that do not represent operating economics, making the trailing multiple look cheap for reasons unrelated to business fundamentals. A more appropriate framework is EV/EBITDA cross-checked against normalized operating margin and ROIC, or price-to-normalized-operating-earnings, since EBITDA better strips out settlement-accounting distortions that have driven gross margins from -179% to 90% in adjacent periods. Investors should also apply Western Union-style earnings-through-the-cycle analysis only with caution, as IMXI's revenue base has halved in two years and deferred revenue has been zero for five straight quarters, meaning any multiple built on historical earnings will overstate the recurring earnings stream until revenue stabilizes.